Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Taxotere

Taxotere is a medicine containing the active ingredient(s) docetaxel. On this page you will find out more about Taxotere, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: docetaxel

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Taxotere 80 mg/4 mL concentrated injection, 4 mL vial

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Breast Cancer Metastatic Breast Cancer - TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. TAXOTERE in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. TAXOTERE in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress HER2 and who previously have not received chemotherapy for metastatic disease. Adjuvant Breast Cancer - TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with node-positive breast cancer. Doxorubicin and cyclophosphamide followed by TAXOTERE in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress HER2. TAXOTERE in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress HER2.Taxotere in combination with cyclophosphamide is indicated for the adjuvant treatment of operable breast cancer with a primary tumour of = 1cm and < 7cm. Non Small-Cell Lung Cancer - TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer, including those who have failed platinum-based chemotherapy. Ovarian Cancer - TAXOTERE is indicated for the treatment of metastatic carcinoma of the ovary after failure of first-line or subsequent chemotherapy. Prostate Cancer - TAXOTERE is indicated for the treatment of patients with androgen independent (hormone refractory) prostate cancer. Head and Neck Cancer - TAXOTERE, in combination with cisplatin and fluorouracil, is indicated as induction treatment prior to chemoradiotherapy, for the treatment of patients with locally advanced, squamous cell carcinoma of the head and neck, who have low probability of surgical cure, require organ preservation or where the tumour is technically unresectable.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Pale yellow to brownish yellow liquid
Dosage Form Injection, concentrated
Route of administration Intravenous
Medicine schedule
1 x 80mg/4mL vial: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions Protect from Light
Life time 3 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 6 results

Chemotherapy drugs- Taxotere

Medical information about Taxotere, a chemotherapy medicine used to treat breast cancer, ovarian cancer, lung cancer and prostate cancer.

Read more on myVMC – Virtual Medical Centre website

Taxotere 1 Vial Concentrate solution for infusion - myDr.com.au

Taxotere 1 Vial Concentrate solution for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Chemotherapy | myVMC

Chemotherapry treatment and side effects information on chemotherapy and cancer drug medical treatment news.

Read more on myVMC – Virtual Medical Centre website

Breast cancer: treatments - myDr.com.au

There are a number of factors to be considered before a doctor selects the right treatment for someone with breast cancer.

Read more on myDr website

Nexavar Tablets - myDr.com.au

Nexavar Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Breast cancer Q and A - myDr.com.au

Breast cancer is the most common cancer among women. Fortunately, much research has been done into its treatment and causes. Find out the latest about breast cancer.

Read more on myDr website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback